Pacific Biosciences Posts Q3 Revenues of $10.5M, Lowers Revenue Guidance | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Pacific Biosciences reported after the close of the market Thursday that its third-quarter revenues fell 1 percent sequentially but beat analysts' consensus estimates on the top and bottom line.

The firm also lowered its revenue guidance for the year based on its current backlog of instrument orders.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.